Atlas Trials

Study to Evaluate the Safety, Pharmacokinetics and Tolerability of BMS-708163

Clinical trial NCT01454115 · COMPLETED

Trial details

NCT number
NCT01454115
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2007-06-01
Primary completion
2009-03-01
Enrollment
116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.